clofibrate did not have any statistically significant effect in reducing the rate of non-fatal infarction in patients with angina or in those with myocardial infarction and pre-existing angina , though a beneficial trend was evident when both subgroups were combined ( a 44 % reduction compared with the placebo group ) .
C0021308
infarction
C0027051
myocardial infarction